1 – 15 of 30
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma (
- 2019
- Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion (
- 2018
- Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years (
- EURO-B.O.S.S. : A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma (
- 2015
- Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register. (
- RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts. (
- Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma. (
- 2014
- Fetthaltiga mjukdelstumörer i rörelseapparaten ofta godartade. (
- Integrative Genome and Transcriptome Analyses Reveal Two Distinct Types of Ring Chromosome in Soft Tissue Sarcomas. (
- Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma. (
- 2013
- A Benign Vascular Tumor With a New Fusion Gene: EWSR1-NFATC1 in Hemangioma of the Bone. (
- Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the wnt/beta-catenin signaling pathway. (
- Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. (
- 2012
- The MDM2 SNP309 G allele is not preferentially amplified in bone and soft tissue tumors. (
- Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma. (